NASDAQ:NXGL NEXGEL (NXGL) Stock Price, News & Analysis → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free NXGL Stock Alerts $2.08 +0.02 (+0.97%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$2.08▼$2.1550-Day Range$2.06▼$2.7352-Week Range$1.46▼$3.14Volume4,382 shsAverage Volume17,473 shsMarket Capitalization$12.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get NEXGEL alerts: Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. About NEXGEL Stock (NASDAQ:NXGL)NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Read More NXGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXGL Stock News HeadlinesJune 1 at 2:48 AM | americanbankingnews.comNEXGEL (NASDAQ:NXGL) Shares Up 1%May 17, 2024 | msn.comNEXGEL Expands Beauty Portfolio with Acquisition of Silly GeorgeMay 16, 2024 | globenewswire.comNEXGEL Acquires International Beauty Brand, Silly GeorgeMay 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Talphera (TLPH), NexGel Inc (NXGL)May 15, 2024 | msn.comNEXGEL Reports Double-Digit Revenue Growth Amid Strategic ExpansionMay 14, 2024 | msn.comNEXGEL, Inc. (NASDAQ:NXGL) Q1 2024 Earnings Call TranscriptMay 13, 2024 | finance.yahoo.comNEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-YearMay 12, 2024 | markets.businessinsider.comNexGel is about to announce earnings — here's what Wall Street expectsMay 11, 2024 | msn.comNEXGEL to Unveil First Quarter Financial Results and Host Conference CallMay 9, 2024 | finance.yahoo.comNEXGEL to Report First Quarter 2024 Financial Results on May 13thMay 6, 2024 | finance.yahoo.comNEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024April 21, 2024 | msn.comNEXGEL CEO to Spotlight Company at Planet MicroCap ShowcaseApril 18, 2024 | finance.yahoo.comNEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024April 17, 2024 | msn.comNEXGEL (NXGL) Price Target Decreased by 14.29% to 6.12April 4, 2024 | finance.yahoo.comABBV Mar 2025 180.000 putApril 3, 2024 | markets.businessinsider.comNexGel Inc: Sustained Buy Rating Amid Growth and Strategic PositivityApril 3, 2024 | msn.comNEXGEL's Engineered Growth: A Triumph in Operational Efficiency and Strategic PartnershipsApril 1, 2024 | globenewswire.comNEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-YearMarch 31, 2024 | msn.comNEXGEL Announces Q4 and Full-Year 2023 Earnings Call DateMarch 27, 2024 | globenewswire.comNEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to HolidayMarch 25, 2024 | msn.comNEXGEL Sets Date for Q4 and Full-Year 2023 Earnings RevealMarch 21, 2024 | globenewswire.comNEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28thMarch 4, 2024 | globenewswire.comNEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12thFebruary 24, 2024 | msn.comNEXGEL (NXGL) Price Target Increased by 16.67% to 7.14February 23, 2024 | msn.comNEXGEL Raises Capital, Strengthens Balance Sheet Amid Growth OpportunitiesSee More Headlines Receive NXGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NEXGEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/01/2024Today6/01/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NXGL CUSIPN/A CIK1468929 Webnexgel.com Phone215-702-8550FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,160,000.00 Net Margins-67.48% Pretax Margin-69.38% Return on Equity-54.71% Return on Assets-31.35% Debt Debt-to-Equity Ratio0.20 Current Ratio1.96 Quick Ratio1.41 Sales & Book Value Annual Sales$4.74 million Price / Sales2.74 Cash FlowN/A Price / Cash FlowN/A Book Value$0.84 per share Price / Book2.48Miscellaneous Outstanding Shares6,228,000Free Float4,537,000Market Cap$12.95 million OptionableNot Optionable Beta0.80 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Adam R. Levy (Age 61)CEO, President & Director Comp: $334.51kMr. Adam E. Drapczuk III (Age 48)Chief Financial Officer Comp: $131.04kMr. Gregory RobbVice President of OperationsKey CompetitorsCarmellNASDAQ:CTCXCytosorbentsNASDAQ:CTSOIceCure MedicalNASDAQ:ICCMLucid DiagnosticsNASDAQ:LUCDBeyond AirNASDAQ:XAIRView All CompetitorsInsiders & InstitutionsNortheast Financial Group Inc.Bought 11,848 shares on 4/15/2024Ownership: 0.190%Scott Robert HenryBought 23,697 shares on 3/1/2024Total: $50,000.67 ($2.11/share)Adam E Drapczuk IIIBought 47,394 shares on 3/1/2024Total: $100,001.34 ($2.11/share)Steven Mark GlassmanBought 3,885 shares on 12/22/2023Total: $8,547.00 ($2.20/share)John Nachum SteinBought 2,500 shares on 9/26/2023Total: $4,900.00 ($1.96/share)View All Insider TransactionsView All Institutional Transactions NXGL Stock Analysis - Frequently Asked Questions How have NXGL shares performed in 2024? NEXGEL's stock was trading at $2.13 on January 1st, 2024. Since then, NXGL shares have decreased by 2.3% and is now trading at $2.08. View the best growth stocks for 2024 here. Are investors shorting NEXGEL? NEXGEL saw a increase in short interest in May. As of May 15th, there was short interest totaling 20,800 shares, an increase of 18.2% from the April 30th total of 17,600 shares. Based on an average daily volume of 22,300 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.4% of the company's stock are sold short. View NEXGEL's Short Interest. When is NEXGEL's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our NXGL earnings forecast. How were NEXGEL's earnings last quarter? NEXGEL, Inc. (NASDAQ:NXGL) announced its earnings results on Monday, April, 1st. The company reported ($0.19) earnings per share for the quarter. The company earned $1.08 million during the quarter. NEXGEL had a negative trailing twelve-month return on equity of 54.71% and a negative net margin of 67.48%. What guidance has NEXGEL issued on next quarter's earnings? NEXGEL updated its first quarter 2024 earnings guidance on Monday, April, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.3 million-$1.3 million, compared to the consensus revenue estimate of $1.2 million. When did NEXGEL IPO? NEXGEL (NXGL) raised $14 million in an initial public offering on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at a price of $6.83 per share. Maxim Group LLC served as the underwriter for the IPO. Who are NEXGEL's major shareholders? NEXGEL's stock is owned by many different institutional and retail investors. Top institutional shareholders include Northeast Financial Group Inc. (0.19%). Insiders that own company stock include Adam E Drapczuk III, Adam R Levy, David Stefansky, Jerome B Zeldis, John Nachum Stein, Nachum Stein, Scott Robert Henry and Steven Mark Glassman. View institutional ownership trends. How do I buy shares of NEXGEL? Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NXGL) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.